Cargando…
Very low LDL‐C levels may safely provide additional clinical cardiovascular benefit: the evidence to date
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in Europe and increased low‐density lipoprotein cholesterol (LDL‐C) is a major contributor to CVD risk. Extensive evidence from clinical studies of statins has demonstrated a linear relationship between LDL‐C levels and CVD risk....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215677/ https://www.ncbi.nlm.nih.gov/pubmed/27739167 http://dx.doi.org/10.1111/ijcp.12881 |